Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2018 | 03-2018 | 09-2017 | 03-2017 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,471 | 10,318 | 23,806 | 5,106 | 5,758 |
| Other current assets | 2,188 | 2,860 | 2,270 | 4,199 | 1,389 |
| TOTAL | $9,705 | $13,178 | $27,037 | $9,305 | $7,948 |
| Non-Current Assets | |||||
| PPE Net | 191 | 238 | 222 | 386 | 533 |
| Intangibles | 423 | 427 | 430 | 426 | 309 |
| Other Non-Current Assets | 0 | 0 | 0 | 1,517 | 605 |
| TOTAL | $614 | $665 | $652 | $2,329 | $1,447 |
| Total Assets | $10,319 | $13,843 | $27,689 | $11,634 | $9,395 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 2,000 | 2,000 |
| Accounts payable and accrued liabilities | 1,685 | 3,957 | 3,991 | 7,434 | 1,632 |
| TOTAL | $3,950 | $3,957 | $13,362 | $9,434 | $7,675 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 605 | 0 | 0 | 0 | 0 |
| TOTAL | $605 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,555 | $3,957 | $13,362 | $9,434 | $7,675 |
| Shareholders' Equity | |||||
| Common Shares | 1,265 | 1,265 | 1,265 | 1,265 | 936 |
| Retained earnings | -29,927 | -25,685 | -21,082 | -33,303 | -22,610 |
| Other shareholders' equity | 1,162 | 1,042 | 880 | 870 | 867 |
| TOTAL | $5,764 | $9,886 | $14,327 | $2,200 | $1,720 |
| Total Liabilities And Equity | $10,319 | $13,843 | $27,689 | $11,634 | $9,395 |